UK Liver Alliance

The UK Liver Alliance is a coalition of more than 30 organisations who are committed to improving liver health.

The Alliance brings together the liver disease community so that it can work in partnership to prevent the development of liver disease, reduce liver disease mortality and improve the care for people with or at risk of liver disease across the UK. It aims to build on the work previously carried out under the auspices of the Lancet Commission.

Membership is open to patient groups, charities, medical royal colleges, NHS organisations, treatment providers and government departments who are committed to preventing liver disease and improving liver health. If your organisation would like to join the alliance please email ukla@britishlivertrust.org.uk

Alliance aims

The UK Liver Alliance has been set up to prevent the development of liver disease, to reduce liver disease mortality and to improve the care for people with or at risk of liver disease across all 4 nations of the UK by

Influencing national policy to improve liver health and supporting the prevention agenda, with other organisations, to develop and deliver public health strategies.
Improving quality and standards of a patient, family and next of kin, focussed clinical service.
Generating and evaluating data on burden of liver disease in the UK to provide a robust evidence base.
Securing an appropriate work force to provide care for people with liver disease.
Removing inequalities and unwarranted variations in care across UK Nations and regions.

Priority workstreams

The UK Liver Alliance has established workstreams in three key areas: early detection, reducing inequalities, and workforce development. Work will be developed with liver disease patients as experts by experience. The workstreams will develop a comprehensive evidence base to inform best practice in the NHS and to advocate with policy-makers, government and legislators.

The UKLA Chairs

Pamela Healy OBE

Chair of the UK Liver Alliance & Chief Executive of the British Liver Trust

Professor Phil Newsome PhD, FRCPE

Vice Chair of the UK Liver Alliance & Director for the Roger Williams Institute of Hepatology